AcelRx CEO buys 10,000 shares
| ACRXDelisted Stock | USD 1.01 0.01 1.00% |
Slightly above 50% of AcelRx Pharmaceuticals' investors are presently thinking to get in. The analysis of current outlook of investing in AcelRx Pharmaceuticals suggests that some traders are interested regarding AcelRx Pharmaceuticals' prospects. AcelRx Pharmaceuticals' investing sentiment can be driven by a variety of factors including economic data, AcelRx Pharmaceuticals' earnings reports, geopolitical events, and overall market trends.
AcelRx |
AcelRx shares up 4 percent after CEO Vincent Angotti discloses the purchase of 10,000 shares of the company for a transaction value of 7,950.Angotti now owns 91,805 shares of...
Read at seekingalpha.com
 |
AcelRx Pharmaceuticals Fundamental Analysis
We analyze AcelRx Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AcelRx Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AcelRx Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Z Score
Z Score Comparative Analysis
AcelRx Pharmaceuticals is currently under evaluation in z score category among its peers. Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
AcelRx Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with AcelRx Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of AcelRx Pharmaceuticals could also be used in its relative valuation, which is a method of valuing AcelRx Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
AcelRx Pharmaceuticals Related Equities
| ASRT | Assertio Therapeutics | 4.06 | ||||
| LFCR | Lifecore Biomedical | 2.93 | ||||
| AMRX | Amneal Pharmaceuticals, | 1.29 | ||||
| TLRY | Tilray | 0.88 | ||||
| ORGO | Organogenesis Holdings | 0.85 | ||||
| AQST | Aquestive Therapeutics | 1.28 | ||||
| EVOK | Evoke Pharma | 2.65 | ||||
| SHPH | Shuttle Pharmaceuticals | 3.60 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Consideration for investing in AcelRx Stock
If you are still planning to invest in AcelRx Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AcelRx Pharmaceuticals' history and understand the potential risks before investing.
| CEOs Directory Screen CEOs from public companies around the world | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |